Prostate cancer patients treated with zoledronic acid suffer renal impairment
Tuesday, June 30th, 2009 Posted in prostate cancer risks | No Comments »According to a report by Dr. Oh and colleagues in the online version of Cancer, nearly one-quarter of prostate cancer (CaP) patients treated with zoledronic acid (ZA) suffer renal impairment ZA is an intravenous bisphosphonate given to decrease skeletal related events ...
Prostate cancer screening not very beneficial, say scientists
Monday, June 29th, 2009 Posted in prostate cancer diagnosis | No Comments »No major medical group, including the American Cancer Society, currently recommends routine prostate cancer screening for men at average risk. The recent release of two large randomized trials, at the American Cancer Society and, respectively, at the University of Texas Health ...
Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer
Sunday, June 28th, 2009 Posted in radiation therapy | No Comments »A scietific team at Harvard Medical School, Boston, MA.has reported on quality of life of a small group of patients receiving salvage brachytherapy following the failure of first-line external beam radiation for localized prostate cancer. The authors report that, patients ...
Risk of erectile dysfunction after prostate cancer
Saturday, June 27th, 2009 Posted in prostate cancer risks | No Comments »Risk for erectile dysfunction (ED) after prostate cancer treatment is commonly assumed to be a reason why many men avoid being tested for their risk for prostate cancer. Whether that is really true or not is actually not well understood. The ...
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?
Friday, June 26th, 2009 Posted in prostate cancer | No Comments »A recent review at Department of Epidemiology of Harvard School of Public Health have compiled data from a pathological analysis on > 800 biopsy and radical prostatectomy specimens. The study conclusion clearly suggests that prostate cancer tumors with a Gleason ...
What are the symptoms of prostate cancer?
Thursday, June 25th, 2009 Posted in prostate cancer diagnosis | No Comments »According to the National Cancer Institute, nearly 16 percent of men born today will be diagnosed with cancer of the prostate at some time during their lifetime and the biggest risk factor for this type of cancer is age. Urologists ...
Outcomes from different types of radical prostatectomy
Wednesday, June 24th, 2009 Posted in prostatectomy | No Comments »A study aiming to determine the cancer control afforded by radical prostatectomy in patients who underwent either an open, laparoscopic, or robotic procedure for localized prostate cancer has been recently completed at University Paris VI, Paris, France. Although open radical prostatectomy ...
Experimental drug killed off inoperable prostate cancer cells
Tuesday, June 23rd, 2009 Posted in prostate cancer | No Comments »Two men with inoperable prostate cancer have made dramatic recoveries after being given a single dose of an experimental drug. They were taking part in a trial involving a drug called ipilimumab, a specially-engineered antibody that boosts the immune system's ...
Collaboration in prostate cancer is vital in order to look for new biomarkers
Monday, June 22nd, 2009 Posted in prostate cancer | No Comments »The focus on the benefit to the patient is amongst the goals of the two-day Prostate Cancer Translational Research in Europe (PCTRE) Meeting which opened today in Amsterdam, The Netherlands. According to participants, the incidence of prostate cancer will increase and ...
‘Surprise’ prostate result probed
Sunday, June 21st, 2009 Posted in prostate cancer | No Comments »Researchers are probing an unexpected success in a study of an experimental treatment for prostate cancer. In three men with advanced disease, use of an immune drug called ipilimumab, shrank their tumours to such an extent surgeons were able to operate. ...